IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$6.34
+0.13 (+2.09%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+763.9% upside
Low Target
$41.45
Average Target
$54.77
High Target
$77.23
Current Price
$6.34
Current
$6.34
$6.34
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Scenario Analysis
Bear Case
$41.45
553.8%
Low target
Base Case
$54.77
+763.9%
Avg target
Bull Case
$77.23
+1,118.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.39
-0.8% from high
52-Week Low
$1.76
+260.2% from low
50-Day SMA
$4.30
+47.4% vs SMA
RSI (14)
55.3
Neutral
Target vs 52W High
$54.77
+757.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |